CircSATB1 Promotes Colorectal Cancer Liver Metastasis through Facilitating FKBP8 Degradation via RNF25-Mediated Ubiquitination

被引:0
|
作者
Zhang, Chuan [1 ]
Tian, Chuanxin [1 ]
Zhu, Renzhong [2 ]
Chen, Chen [1 ]
Jin, Chi [1 ]
Wang, Xiaowei [1 ]
Sun, Lejia [1 ]
Peng, Wen [1 ]
Ji, Dongjian [1 ]
Zhang, Yue [1 ]
Sun, Yueming [1 ]
机构
[1] Nanjing Med Univ, Colorectal Inst Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210000, Peoples R China
[2] Yangzhou Univ, Inst Translat Med, Med Coll, Yangzhou 225000, Peoples R China
关键词
circSATB1; colorectal cancer; FKBP8; liver metastasis; RNF25; CIRCULAR RNA; PROTEIN; INHIBITOR; EXOSOMES; SATB1; MTOR;
D O I
10.1002/advs.202406962
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Colorectal cancer (CRC) is one of the most common cancers worldwide and liver metastasis is the leading reason for its mortality. Circular RNAs (circRNAs) are conclusively associated with the progression of various cancers, rendering the exploration of its specific mechanisms in colorectal cancer liver metastasis(CRLM) highly valuable. Combined with GEO (Gene Expression Omnibus) databases and clinical data in our center, we found that high expression of circSATB1 is closely related to the progression of CRLM. Functionally, circSATB1 could significantly promote the metastatic ability of CRC cells in vitro and in vivo. Mechanistically, circSATB1 facilitated the RNF25-mediated ubiquitylation and degradation of FKBP8, releasing its inhibitory effects on mTOR signaling. In this process, circSATB1 acted as a scaffold for RNF25-FKBP8 complexes. Additionally, circSATB1 could be packaged in exosomes and secreted from the CRC primary tumors into plasma. In conclusion, this study uncovered a new circSATB1 that acts as a potent promoter of CRLM and offers novel insights into the precision therapeutic strategies for CRLM.
引用
收藏
页数:18
相关论文
共 6 条
  • [1] Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy
    Shen, Tong
    Cai, Ling-Dong
    Liu, Yu-Hong
    Li, Shi
    Gan, Wen-Juan
    Li, Xiu-Ming
    Wang, Jing-Ru
    Guo, Peng-Da
    Zhou, Qun
    Lu, Xing-Xing
    Sun, Li-Na
    Li, Jian-Ming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [2] Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy
    Tong Shen
    Ling-Dong Cai
    Yu-Hong Liu
    Shi Li
    Wen-Juan Gan
    Xiu-Ming Li
    Jing-Ru Wang
    Peng-Da Guo
    Qun Zhou
    Xing-Xing Lu
    Li-Na Sun
    Jian-Ming Li
    Journal of Hematology & Oncology, 11
  • [3] SUB1 promotes colorectal cancer metastasis by activating NF-κB signaling via UBR5-mediated ubiquitination of UBXN1
    Wang, Hao
    Chen, Wenwen
    Wang, Yanting
    Gao, Yuzhen
    Zhang, Zizhen
    Mi, Shuyi
    Wang, Liangjing
    Xue, Meng
    SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (06) : 1199 - 1211
  • [4] Circular RNA circ-ADD3 inhibits hepatocellular carcinoma metastasis through facilitating EZH2 degradation via CDK1-mediated ubiquitination
    Sun, Suofeng
    Wang, Wei
    Luo, Xiaoying
    Li, Yuan
    Liu, Bowei
    Li, Xiaofang
    Zhang, Binong
    Han, Shuangyin
    Li, Xiuling
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (08): : 1695 - +
  • [5] CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening
    Guangshun Sun
    Siqi Zhao
    Zhongguo Fan
    Yuliang Wang
    Hanyuan Liu
    Hengsong Cao
    Guoqiang Sun
    Tian Huang
    Hongzhou Cai
    Hong Pan
    Dawei Rong
    Yun Gao
    Weiwei Tang
    Journal of Experimental & Clinical Cancer Research, 42
  • [6] CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening
    Sun, Guangshun
    Zhao, Siqi
    Fan, Zhongguo
    Wang, Yuliang
    Liu, Hanyuan
    Cao, Hengsong
    Sun, Guoqiang
    Huang, Tian
    Cai, Hongzhou
    Pan, Hong
    Rong, Dawei
    Gao, Yun
    Tang, Weiwei
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)